XML 28 R46.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Long-Term Incentive Employee Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Long-Term Incentive Employee Compensation Costs | Long-term incentive employee compensation costs are primarily recorded within general and administrative expenses, and are reduced by an estimated forfeiture rate. These costs impacted our consolidated results of operations as follows:
| 2013 |  |  | 2012 |  |  | 2011 |
Share-based compensation expense, equity-based awards | $ | 13.3 |  |  | $ | 12.9 |  |  | $ | 23.3 |
Share-based compensation expense, liability-based awards | 3.8 |  |  | 1.9 |  |  | 2.1 |
Total share-based compensation expense in operating income (loss)(a) | $ | 17.1 |  |  | $ | 14.8 |  |  | $ | 25.4 |
(a) | Share-based compensation expense incurred during 2013, 2012, and 2011 includes $0.2, $0.5 and $4.7, respectively, classified as a transformation cost in the Consolidated Statements of Operations related to the modification of equity awards. Also, included in 2011 is $8.3 of accelerated expense recognition primarily related to the retirement of Steven R. Loranger, our former Chairman, President and Chief Executive Officer.
Status of Stock Option and Restricted Stock Shares | A summary of the status of our NQOs as of December 31, 2013, 2012 and 2011 and changes during the years then ended is presented below.
| 2013 |  | 2012 |  | 2011
Stock Options | Shares |  |  | Weighted Average Exercise Price |  |  | Shares |  |  | Weighted Average Exercise Price |  |  | Shares |  |  |  | Weighted Average Exercise Price |
Outstanding – January 1 | 4.3 |  |  | $ | 18.46 |  |  | 8.0 |  |  | $ | 16.70 |  |  | 3.7 |  |  |  | $ | 85.08 |
Granted | 0.4 |  |  | 26.82 |  |  | 0.4 |  |  | 22.80 |  |  | 0.3 |  |  |  | 115.36 |
Exercised | (1.9 | ) |  | 17.37 |  |  | (3.8 | ) |  | 15.35 |  |  | (0.7 | ) |  |  | 76.27 |
Cancelled or expired | (0.1 | ) |  | 16.15 |  |  | (0.3 | ) |  | 17.21 |  |  | (1.3 | ) | (b) |  | 92.76 |
Outstanding on Distribution Date before Equitable Adjustment | — |  |  | — |  |  | — |  |  | — |  |  | 2.0 |  |  |  | 88.52 |
Outstanding on Distribution Date after Equitable Adjustment | — |  |  | — |  |  | — |  |  | — |  |  | 8.0 |  |  |  | 16.18 |
November/December 2011 Activity: |  |  |  |  |  |  |  |  |  |  |  |
Granted | — |  |  | — |  |  | — |  |  | — |  |  | 0.7 |  |  |  | 20.28 |
Exercised | — |  |  | — |  |  | — |  |  | — |  |  | (0.7 | ) |  |  | 13.87 |
Outstanding – December 31 | 2.7 |  |  | $ | 20.46 |  |  | 4.3 |  |  | $ | 18.46 |  |  | 8.0 |  |  |  | $ | 16.70 |
Options exercisable – December 31 | 1.5 |  |  | $ | 18.34 |  |  | 2.9 |  |  | $ | 17.10 |  |  | 6.3 |  |  |  | $ | 16.03 |
(b) | Includes 1.2 shares cancelled in connection with the Distribution of Exelis and Xylem, with a corresponding weighted average exercise price of $92.20.
Share-Based Compensation Summary of Stock Options | The following table summarizes information about ITT’s stock options at December 31, 2013:
| Options Outstanding |  | Options Exercisable
Range of Exercise Prices | Number |  |  | Weighted Average Remaining Contractual Life (in years) |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value |  |  | Number |  |  | Weighted Average Remaining Contractual Life (in years) |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value |
$12-$15 | 0.5 |  |  | 1.1 |  | $ | 13.19 |  |  | $ | 14.0 |  |  | 0.5 |  |  | 1.1 |  |  | $ | 13.19 |  |  | $ | 14.0 |
$15-$20 | 0.4 |  |  | 4.5 |  | 19.92 |  |  | 9.7 |  |  | 0.4 |  |  | 4.5 |  |  | 19.92 |  |  | 9.7 |
$20-$25 | 1.4 |  |  | 7.1 |  | 21.39 |  |  | 31.9 |  |  | 0.6 |  |  | 6.1 |  |  | 20.94 |  |  | 15.0 |
$25-$30 | 0.4 |  |  | 9.2 |  | 26.82 |  |  | 5.8 |  |  | — |  |  | — |  |  | — |  |  | — |
| 2.7 |  |  | 6.0 |  | $ | 20.46 |  |  | $ | 61.4 |  |  | 1.5 |  |  | 4.2 |  |  | $ | 18.34 |  |  | $ | 38.7 |
Weighted Average Assumptions | The following are weighted-average assumptions for 2013, 2012 and 2011:
| 2013 |  |  | 2012 |  |  | November 7, 2011 Grants |  |  | 2011 Grants Before Distribution |
Dividend yield | 1.5 | % |  | 1.6 | % |  | 1.8 | % |  | 1.7 | %
Expected volatility | 29.9 | % |  | 34.1 | % |  | 39.3 | % |  | 24.7 | %
Expected life (in years) | 6.4 |  |  | 6.9 |  |  | 7.0 |  |  | 7.0 |
Risk-free rates | 1.1 | % |  | 1.4 | % |  | 1.5 | % |  | 3.1 | %
Weighted-average grant date fair value | $ | 6.62 |  |  | $ | 6.71 |  |  | $ | 6.97 |  |  | $ | 29.70 |
Rollforward of Outstanding Restricted Stock | The table below provides a rollforward of outstanding RSUs, PSUs, and RSAs for each of the years ended December 31, 2013, 2012 and 2011.
| 2013 |  | 2012 |  | 2011
Restricted Stock and Performance Units | Shares |  |  | Weighted Average Grant Date Fair Value |  |  | Shares |  |  | Weighted Average Grant Date Fair Value |  |  | Shares |  |  |  | Weighted Average Grant Date Fair Value |
Outstanding – January 1 | 1.2 |  |  | $ | 21.06 |  |  | 1.4 |  |  | $ | 18.55 |  |  | 0.9 |  |  |  | $ | 89.70 |
Granted | 0.6 |  |  | 28.16 |  |  | 0.4 |  |  | 22.56 |  |  | 0.3 |  |  |  | 115.18 |
Lapsed | (0.4 | ) |  | 20.25 |  |  | (0.5 | ) |  | 15.21 |  |  | (0.3 | ) |  |  | 99.53 |
Canceled | (0.1 | ) |  | 22.68 |  |  | (0.1 | ) |  | 20.58 |  |  | (0.6 | ) | (c) |  | 95.30 |
Outstanding on Distribution Date before equitable adjustment | — |  |  | — |  |  | — |  |  | — |  |  | 0.3 |  |  |  | 93.42 |
Outstanding on Distribution Date after equitable adjustment | — |  |  | — |  |  | — |  |  | — |  |  | 1.0 |  |  |  | 17.94 |
November/December 2011 Activity: |  |  |  |  |  |  |  |  |  |  |  |
Granted | — |  |  | — |  |  | — |  |  | — |  |  | 0.4 |  |  |  | 20.27 |
Outstanding – December 31 | 1.3 |  |  | $ | 24.17 |  |  | 1.2 |  |  | $ | 21.06 |  |  | 1.4 |  |  |  | $ | 18.55 |
(c) | Includes a total of 0.5 RSUs and RSAs canceled in connection with the Distribution of Exelis and Xylem, with a corresponding weighted average grant date fair value of $95.14.
Number of Outstanding Equity Settled RSUs, Cash Settled RSUs and RSAs | The table below provides the number of the outstanding equity settled RSUs, PSU's, RSA's and cash settled RSUs as of December 31, 2013, 2012 and 2011.
| 2013 |  |  | 2012 |  |  | 2011 |
Equity settled RSUs | 1.0 |  |  | 0.9 |  |  | 0.8 |
Cash settled RSUs | 0.1 |  |  | 0.1 |  |  | 0.1 |
PSUs | 0.2 |  |  | — |  |  | — |
RSAs | — |  |  | 0.2 |  |  | 0.5 |

X
- Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of share-based compensation plans that may be presented in a single table for outstanding, vested and expected to vest, and exercisable awards. The information that may be disclosed in this table may include, but is not limited to, number of shares, weighted average exercise price, weighted average remaining contractual life, and aggregate intrinsic value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration